Mode
Text Size
Log in / Sign up

SUVmax demonstrates moderate accuracy in predicting lymphovascular space invasion in endometrial cancer patientsPET scan measure predicts cancer spread risk with moderate accuracy

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that SUVmax shows moderate accuracy (AUROC 0.77) for noninvasively predicting lymphovascular space invasion.

This meta-analysis evaluates the diagnostic performance of SUVmax (maximum standardized uptake value) from PET/CT or PET/MR imaging in predicting lymphovascular space invasion (LVSI) among patients with endometrial cancer. The primary objective was to determine if noninvasive imaging metrics can accurately identify LVSI, a critical prognostic factor.

The meta-analysis reported an AUROC of 0.77 for SUVmax in detecting LVSI. Specifically, the sensitivity for identifying LVSI was 62%, while the specificity was 83%. These findings suggest that SUVmax provides moderate diagnostic accuracy for predicting LVSI in this patient population.

Authors noted that results may be unstable as one specific study contributed significantly to the variance during sensitivity analysis. They concluded that more original studies with larger sample sizes are required to further validate the role of SUVmax in differentiating LVSI. Clinical application is currently limited by these uncertainties, but it offers a noninvasive method for assessment.

How this fits prior evidence

This meta-analysis addresses a gap in noninvasive diagnostic tools for endometrial cancer. While prior evidence confirms that combined pelvic and para-aortic lymphadenectomy improves overall survival in endometrial cancer, the specific risk subgroups remain unconfirmed. This study provides data on SUVmax as a potential predictor of LVSI, which may inform risk stratification, though it currently offers only moderate accuracy.

For women with endometrial cancer, knowing whether the cancer has spread to nearby lymph vessels is crucial for treatment decisions. Currently, that requires surgery. But a new analysis of 257 patients suggests a noninvasive PET scan measure might help.

The measure, called SUVmax, looks at how much sugar the cancer cells take up on a PET scan. The analysis found that SUVmax can detect lymphovascular space invasion (LVSI) with 83% specificity, meaning it correctly rules out the spread in most cases. Its sensitivity was 62%, so it misses some cases. Overall accuracy was moderate, with an AUROC of 0.77.

However, the results may be less reliable than they appear. One study in the analysis had a big influence on the findings, and more research with larger groups is needed. This is not yet ready for routine use, but it offers a glimpse of a future where some women might avoid surgery to check for spread.

What this means for you:
SUVmax from PET scans shows moderate accuracy for predicting lymph vessel invasion in endometrial cancer, but more research is needed.

Common questions

What is SUVmax and how is it measured?

SUVmax stands for maximum standardized uptake value. It is a number calculated from a PET scan that shows how active the cells are. Cancer cells often take up more sugar, so a higher SUVmax can indicate more aggressive cancer. It is measured noninvasively during a PET/CT or PET/MR scan.

How accurate is SUVmax for detecting lymphovascular space invasion?

In this analysis of 257 patients, SUVmax had moderate accuracy. It correctly identified 83% of cases without LVSI (specificity) and detected 62% of cases with LVSI (sensitivity). The overall accuracy, measured by AUROC, was 0.77. However, results may be influenced by one study, so more research is needed.

Can SUVmax replace surgery for checking cancer spread?

Not yet. This analysis shows promise, but the accuracy is only moderate, and the results may be unstable. Currently, surgery is still the standard way to check for lymphovascular space invasion. More studies with larger groups are needed before SUVmax could be used alone to guide treatment decisions.

Study Details

Study typeMeta analysis
Sample sizen = 257
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
OBJECTIVES: To evaluate the ability of the maximum standardized uptake value (SUVmax) to predict the lymphovascular space invasion (LVSI) status in endometrial cancer (EC). METHOD: PubMed/MEDLINE, Web of Science, Embase, and the Cochrane Library were systematically searched for all original studies evaluating the diagnostic efficacy of LVSI using PET/CT or PET/MR. Methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). A bivariate random effects model was used to acquire pooled sensitivity, specificity, heterogeneity, and the area under the summary receiver operating characteristic curve (AUROC). Meta-regression and sensitivity analysis were performed to identify sources of heterogeneity. RESULTS: A total of 6 studies (257 patients) were included. Most studies had a low risk of bias, and all studies had minimal applicability concerns. The summary AUROC values, pooled sensitivity and specificity of SUVmax in detecting LVSI in EC were 0.77, 62% and 83%, respectively. One study may have contributed to the unstable results of this study according to the sensitivity analysis. CONCLUSION: Our study showed that SUVmax has moderate accuracy in noninvasively predicting LVSI in EC. More original studies with large samples are needed in the future to evaluate the role of SUVmax in differentiating LVSI. Advances in knowledge: LVSI is closely related to the prognosis of EC, and it can only be obtained by surgical pathology. SUVmax has moderate diagnostic performance in preoperatively predicting LVSI in EC. Future studies with large samples are needed to confirm the clinical value of SUVmax in the preoperative prediction of LVSI.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.